These awards are published in
'Budtenders are the most important influencers in the industry, guiding consumer purchasing decisions every day in retail outlets across the country,' said
Back Forty received top honours in both 'Best
Rounding out Auxly's Kind Awards wins is Dosecann, recognized for its innovative Daily Relief CBD Cream, which garnered the inaugural win for the magazine's new 'Best Topical' category. Dosecann Daily Relief CBD Cream has 1,200 mg of CBD per 60 ml unit - an industry-leading potency that is competitively priced to deliver the best value for a CBD topical. Dosecann Daily Relief CBD Cream combines high-quality CBD extract with Natralipid Meadowfoam seed oil, a plant-based emollient found in high-end skin creams and valued for moisturization, transdermal barrier repair, skin penetration and unsurpassed stability.
These distinctions validate the Company's quality-driven approach to delivering unique cannabis product innovations to Canadian consumers. As the New Year quickly approaches, Auxly will continue to invest in delivering differentiated cannabis products under its award-winning brand portfolio with its sights set on becoming the #1 LP in the country.
About
Auxly is a leading Canadian cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the wellness and adult-use markets. Auxly's experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market.
Contact:
Email: press@auxly.com
Notice Regarding Forward Looking Information
This news release contains certain 'forward-looking information' within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as 'plan', 'continue', 'expect', 'project', 'intend', 'believe', 'anticipate', 'estimate', 'may', 'will', 'potential', 'proposed' and other similar words, or information that certain events or conditions 'may' or 'will' occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: Auxly's execution of its product development and commercialization strategy; the ability of the Company to maintain and grow its market share; consumer preferences, political change, future legislative and regulatory developments involving cannabis and cannabis products and competition and other risks affecting Auxly in particular and the cannabis industry generally.
A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to whether: there is acceptance and demand for Auxly's current and future products by consumers and provincial purchasers and general economic, financial market, regulatory and political conditions in which Auxly operates will remain the same. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.
(C) 2021 Electronic News Publishing, source